|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C12N 15/00 | (2006.01) | ||
| C12N 15/11 | (2006.01) | ||
| C12N 15/12 | (2006.01) | ||
| C12N 15/63 | (2006.01) |
| (11) | Number of the document | 1476185 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02802898.3 |
| Date of filing the European patent application | 2002-11-08 | |
| (97) | Date of publication of the European application | 2004-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-31 |
| (46) | Date of publication of the claims translation | 2013-12-27 |
| (86) | Number | PCT/US2002/036107 |
| Date | 2002-11-08 |
| (87) | Number | WO 2003/040170 |
| Date | 2003-05-15 |
| (30) | Number | Date | Country code |
| 348980 P | 2001-11-09 | US |
| (72) |
BEDIAN, Vahe, US
GLADUE, Ronald, P., US
CORVALAN, Jose, US
JIA, Xiao-Chi, US
FENG, Xiao, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai prieš CD40 |
| ANTIBODIES TO CD40 |
| Payment date | Validity (years) | Amount | |
| 2021-10-22 | 347.00 EUR |